N
NephroPlus
Offers an one stop shop for all of a kidney patient’s needs
About NephroPlus
NephroPlus operates a network of kidney dialysis centers across India and other emerging markets, including the Philippines. The company provides a range of dialysis services, such as in-center hemodialysis, home hemodialysis, and peritoneal dialysis, catering to patients with end-stage renal disease.
Its business model is focused on establishing and managing dialysis centers, often in partnership with hospitals. By offering specialized kidney care, the company addresses a critical healthcare need in regions with a growing prevalence of chronic kidney disease. Revenue is generated through the fees charged for the dialysis treatments and related services provided to patients at its centers.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2009
- Headquarters
- Hyderabad, India
- Employees
- 2,032
- Open positions
- 2
- Dealroom signal
- 91.9/100
- Industry
- Health
- Sub-industry
- Pharmaceutical
- Sector
- Biotech & Life Sciences, Personal Health, Diabetes, Dietary Supplements, Biotechnology, Superfood, Biotech and Pharma
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
- Investment activity
- 2 companies, latest Mar 2024
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| IPOOther financing | Dec 2025 | $97M | — | Undisclosed | ↗ |
| SECONDARYOther financing | May 2024 | $0 | — | Quadria Capital | ↗ |
Financials
Revenue, earnings and other financial measures where available. Years marked “E” are estimates.
Growth signals
Latest recorded traffic for NephroPlus is 30K monthly website visits, up 57.9% over the last three months. NephroPlus's team grew 11.6% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Series B and later5 investors entered at this stage
SeaLink Capital Partners
Investcorp
IIFL 1
IIFL
Quadria Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about NephroPlus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See NephroPlus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.